Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

The AUTS2 gene is linked to neurological disorders and may affect human brain development and cognition.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.